Let us help you find what you're looking for.
Prof Tan Chee Kiat
MBBS (S'pore), MRCP (UK), FRCP (Edin), FAMS, FAASLD, PGDip MedEd (Dundee)
Senior Consultant
Singapore General Hospital
Specialty: Gastroenterology
Conditions Treated By This Doctor
Clinical Interests
Gastroenterology,
Hepatology,
Liver Cancer,
Liver Transplantation,
Viral Hepatitis
About Doctor
Prof Tan Chee Kiat graduated from the Faculty of Medicine, National University of Singapore in 1984. He became a Member of the Royal College of Physicians, United Kingdom [MRCP (UK)] in 1989 and Fellow of the Royal College of Physicians, Edinburgh [(FRCP (Edin)] in 1998. He is also a Fellow of the Academy of Medicine, Singapore in Gastroenterology [FAMS (Gastroenterology)] since 1995. He has trained in Hepatology and Liver Transplantation at the Mayo Clinic, Rochester, Minnesota, USA. He is a fully trained gastroenterologist and besides General Hepatology, his areas of interests are Liver Cancer, Viral Hepatitis and Liver Transplantation. He has set up a nationwide web-based database for hepatocellular carcinoma.
Languages Spoken
- English
Education and Training
- MBBS (S'pore)
- MRCP (UK)
- FRCP (Edin)
- FAMS
- FAASLD
- PGDip MedEd (Dundee)
Awards
- Singapore Cancer Syndicate Grant for development of National Liver Cancer Registry (2004-2009)
- SGH Excellent Publication Award 2003
- Glaxo Research Institute Fellow's Award for basic research 1994
- Ministry of Health Manpower Development Program award 1993-1994
- Singapore Government Local Merit Scholarship for Medicine (1979-1984)
Publications
- TT Chang, CL Lai, S Han, KH Han, S Gordon, YC Chao, CK Tan, et al. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histologic damage. Hepatology (in press).
- S Purushotham, PEJ Chang, H Rumpel, IHC Kee, RTH Ng, PKH Chow, CK Tan, RV Ramanujan. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy. Nanotechnology 2009; 20: 305101. doi:10.1088/09574484/20/30/305101, published 7 July 2009.
- PE Chang, WC Ong, HF Lui, CK Tan. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol 2008; 43:881-888.
- PE Chang, HF Lui, YP Chau, KH Lim, WM Yap, CK Tan, WC Chow. Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminases platelet ratio index. Aliment Pharmacol Ther 2008; 28:51-61.
- Tan CK, Law NM, Ng HS, Machin D. A simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation. J Clin Oncol 2003; 21(12):2294-2298.
- Chow PKH, Tai BC, Tan CK, et al. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: a multicenter randomized trial. Hepatology 2002; 36(5):1221-1226.
- Tan CK, Ho MSJ. Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation. Liver Transpl 2001; 7(5):461-465.
- Tan CK, PKH Chow, Findlay M, et al. The use of tamoxifen in hepatocellular carcinoma – A review and paradigm shift. J Gastroenterol Hepatol 2000; 15(7): 725-9.
- Tan CK, PV Podila, JE Taylor, et al. Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition. Gastroenterology 1995; 108(6): 1908-16.
- Tan CK, Gores GJ, Steers JL, et al. Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc 1994; 69: 509-14.
Stay Healthy The Easy Way
Get trusted health advice, offers and more.
Stay Ahead in Healthcare Industry
Subscribe to our exclusive updates for healthcare professionals.
Stay Healthy With
Follow SGH
